, Hong Kong
105 views
/Ryoji Iwata from Unsplash

Chow Tai Fook boosts CTF Life's brand in Hong Kong: Fitch Ratings

This move contributed to a market share increase to 2.7% in the first half of 2024.

Chow Tai Fook Life Insurance Company Limited's (CTF Life) has shown strong capitalisation, a moderate company profile, and good financial performance, assessed Fitch Ratings.

CTF Life, formerly known as FTLife Insurance Company Limited, has benefited from its rebranding under Chow Tai Fook Group following a 61% stake acquisition by Chow Tai Fook Enterprise Limited in November 2023. 

This move enhanced its brand recognition in Hong Kong and China, contributing to a market share increase to 2.7% in the first half of 2024, up from 2.1% in the same period last year.  

Its Hong Kong risk-based capital ratio rose to 289% in the fiscal year ended June 2024 (FY 2024), compared to 261% in FY 2023, well above the 100% regulatory minimum. 

The absence of debt further bolsters its capital structure.  

Despite strong business growth reflected in a rising annualised premium equivalent, CTF Life reported a decline in its value of new business (VNB) margin due to a shift in product mix. 

However, return on equity improved to 6.1% in FY 2024 from 5% in FY 2023, aided by insurance results under the HKFRS17 accounting standard.  
 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.